The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Repros Therapeutics Inc

Nasdaq: RPRX(*D)
Last

(U.S.) $0.56

Today's change-0.01 -1.19%
Updated May 24 3:59 PM -4GMT. Delayed by at least 15 minutes.
 

Repros Therapeutics Inc

Nasdaq: RPRX(*D)
Last

(U.S.) $0.56

Today's change-0.01 -1.19%
Updated May 24 3:59 PM -4GMT. Delayed by at least 15 minutes.

Repros Therapeutics Inc down (U.S.)$0.01

Repros Therapeutics Inc closed lower Wednesday, dropping (U.S.)$0.01 or 1.19% to (U.S.)$0.56. Over the last five days, shares have lost 30.71% and are down 57.95% for the last year to date. This security has underperformed the S&P 500 by 88.34% during the last year.

Key company metrics

  • Open(U.S.) $0.56
  • Previous close(U.S.) $0.56
  • High(U.S.) $0.60
  • Low(U.S.) $0.56
  • Bid / Ask(U.S.) $0.55 / (U.S.) $0.58
  • YTD % change-57.95%
  • Volume210,584
  • Average volume (10-day)306,750
  • Average volume (1-month)216,671
  • Average volume (3-month)148,545
  • 52-week range(U.S.) $0.51 to (U.S.) $2.48
  • Beta0.67
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.73
Updated May 24 3:59 PM -4GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue--------
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense6444
Selling / general / administrative4422
Research & development1023
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-6-4-4-4
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-6-4-4-4
Income after tax-6-4-4-4
Income tax, total--------
Net income-6-4-4-4
Total adjustments to net income--------
Net income before extra. items-6-4-4-4
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-6-4-4-4
Inc. avail. to common incl. extra. items-6-4-4-4
Diluted net income-6-4-4-4
Dilution adjustment--------
Diluted weighted average shares26262424
Diluted EPS excluding extraordinary itemsvalue per share-0.22-0.16-0.17-0.18
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.22-0.16-0.17-0.18